CISCO SYSTEMS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CISCO SYSTEMS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jul 28, 2018 | $12.84B | Sep 6, 2018 |
| FY2018 | Apr 28, 2018 | $12.46B | Sep 6, 2018 |
| FY2018 | Jan 27, 2018 | $11.89B | Sep 6, 2018 |
| FY2018 | Oct 28, 2017 | $12.14B | Sep 6, 2018 |
| FY2018 | Jul 29, 2017 | $12.13B | Sep 6, 2018 |
| FY2018 | Apr 29, 2017 | $11.94B | Sep 6, 2018 |
| FY2018 | Jan 28, 2017 | $11.58B | Sep 6, 2018 |
| FY2018 | Oct 29, 2016 | $12.35B | Sep 6, 2018 |
| FY2018 | Jul 30, 2016 | $49.25B | Sep 6, 2018 |
| FY2016 | Jul 25, 2015 | $49.16B | Sep 8, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $56.65B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $53.80B | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | $57.00B | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | $51.56B | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | $49.82B | Sep 7, 2023 |
| FY2020 | Jul 25, 2020 | $12.15B | Sep 3, 2020 |
| FY2020 | Apr 25, 2020 | $11.98B | Sep 3, 2020 |
| FY2020 | Jan 25, 2020 | $12.01B | Sep 3, 2020 |
| FY2020 | Oct 26, 2019 | $13.16B | Sep 3, 2020 |
| FY2020 | Jul 27, 2019 | $13.43B | Sep 3, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jul 29, 2017 | $12.13B | Sep 7, 2017 |
| FY2017 | Apr 29, 2017 | $11.94B | Sep 7, 2017 |
| FY2017 | Jan 28, 2017 | $11.58B | Sep 7, 2017 |
| FY2017 | Oct 29, 2016 | $12.35B | Sep 7, 2017 |
| FY2017 | Jul 30, 2016 | $12.64B | Sep 7, 2017 |
| FY2017 | Apr 30, 2016 | $12.00B | Sep 7, 2017 |
| FY2017 | Jan 23, 2016 | $11.93B | Sep 7, 2017 |
| FY2017 | Oct 24, 2015 | $12.68B | Sep 7, 2017 |
| FY2017 | Jul 25, 2015 | $49.16B | Sep 7, 2017 |
| FY2016 | Jul 26, 2014 | $47.14B | Sep 8, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $36.79B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $34.83B | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | $35.75B | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | $32.25B | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | $31.89B | Sep 7, 2023 |
| FY2020 | Jul 25, 2020 | $7.68B | Sep 3, 2020 |
| FY2020 | Apr 25, 2020 | $7.77B | Sep 3, 2020 |
| FY2020 | Jan 25, 2020 | $7.76B | Sep 3, 2020 |
| FY2020 | Oct 26, 2019 | $8.46B | Sep 3, 2020 |
| FY2020 | Jul 27, 2019 | $8.57B | Sep 3, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $10.18B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $10.32B | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | $12.61B | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | $11.81B | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | $10.59B | Sep 7, 2023 |
| FY2020 | Jul 25, 2020 | $2.64B | Sep 3, 2020 |
| FY2020 | Apr 25, 2020 | $2.77B | Sep 3, 2020 |
| FY2020 | Jan 25, 2020 | $2.88B | Sep 3, 2020 |
| FY2020 | Oct 26, 2019 | $2.93B | Sep 3, 2020 |
| FY2020 | Jul 27, 2019 | $2.21B | Sep 3, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $11.76B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $12.18B | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | $15.03B | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | $13.97B | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | $12.83B | Sep 7, 2023 |
| FY2020 | Jul 25, 2020 | $3.25B | Sep 3, 2020 |
| FY2020 | Apr 25, 2020 | $3.41B | Sep 3, 2020 |
| FY2020 | Jan 25, 2020 | $3.38B | Sep 3, 2020 |
| FY2020 | Oct 26, 2019 | $3.58B | Sep 3, 2020 |
| FY2020 | Jul 27, 2019 | $3.69B | Sep 3, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $9.30B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $7.98B | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | $7.55B | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | $6.77B | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | $6.55B | Sep 7, 2023 |
| FY2022 | Jul 25, 2020 | $6.35B | Sep 8, 2022 |
| FY2021 | Jul 27, 2019 | $6.58B | Sep 9, 2021 |
| FY2020 | Jul 28, 2018 | $6.33B | Sep 3, 2020 |
| FY2019 | Jul 29, 2017 | $6.06B | Sep 5, 2019 |
| FY2018 | Jul 30, 2016 | $6.30B | Sep 6, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $14.19B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $10.88B | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | $19.89B | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | $13.23B | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | $15.45B | Sep 7, 2023 |
| FY2022 | Jul 25, 2020 | $15.43B | Sep 8, 2022 |
| FY2021 | Jul 27, 2019 | $15.83B | Sep 9, 2021 |
| FY2020 | Jul 28, 2018 | $13.67B | Sep 3, 2020 |
| FY2019 | Jul 29, 2017 | $13.88B | Sep 5, 2019 |
| FY2018 | Jul 30, 2016 | $13.57B | Sep 6, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $905.00M | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $670.00M | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | $849.00M | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | $477.00M | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | $692.00M | Sep 7, 2023 |
| FY2022 | Jul 25, 2020 | $770.00M | Sep 8, 2022 |
| FY2021 | Jul 27, 2019 | $909.00M | Sep 9, 2021 |
| FY2020 | Jul 28, 2018 | $834.00M | Sep 3, 2020 |
| FY2019 | Jul 29, 2017 | $964.00M | Sep 5, 2019 |
| FY2018 | Jul 30, 2016 | $1.15B | Sep 6, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $122.29B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $124.41B | Sep 3, 2025 |
| FY2024 | Jul 29, 2023 | $101.85B | Sep 5, 2024 |
| FY2023 | Jul 30, 2022 | $94.00B | Sep 7, 2023 |
| FY2022 | Jul 31, 2021 | $97.50B | Sep 8, 2022 |
| FY2021 | Jul 25, 2020 | $94.85B | Sep 9, 2021 |
| FY2020 | Jul 27, 2019 | $97.79B | Sep 3, 2020 |
| FY2019 | Jul 29, 2018 | $109.87B | Sep 5, 2019 |
| FY2019 | Jul 28, 2018 | $108.78B | Sep 5, 2019 |
| FY2018 | Jul 29, 2017 | $129.82B | Sep 6, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $75.45B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $78.96B | Sep 3, 2025 |
| FY2024 | Jul 29, 2023 | $57.50B | Sep 5, 2024 |
| FY2023 | Jul 30, 2022 | $54.23B | Sep 7, 2023 |
| FY2022 | Jul 31, 2021 | $56.22B | Sep 8, 2022 |
| FY2021 | Jul 25, 2020 | $56.93B | Sep 9, 2021 |
| FY2020 | Jul 27, 2019 | $64.22B | Sep 3, 2020 |
| FY2019 | Jul 28, 2018 | $65.58B | Sep 5, 2019 |
| FY2018 | Jul 29, 2017 | $63.68B | Sep 6, 2018 |
| FY2017 | Jul 30, 2016 | $58.07B | Sep 7, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $46.84B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $45.46B | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | $44.35B | Sep 3, 2025 |
| FY2025 | Jul 30, 2022 | $39.77B | Sep 3, 2025 |
| FY2024 | Jul 31, 2021 | $41.28B | Sep 5, 2024 |
| FY2023 | Jul 25, 2020 | $37.92B | Sep 7, 2023 |
| FY2022 | Jul 27, 2019 | $33.57B | Sep 8, 2022 |
| FY2021 | Jul 28, 2018 | $43.20B | Sep 9, 2021 |
| FY2020 | Jul 29, 2017 | $66.14B | Sep 3, 2020 |
| FY2017 | Jul 30, 2016 | $63.59B | Sep 7, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $59.14B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $58.66B | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | $38.54B | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | $38.30B | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | $38.17B | Sep 7, 2023 |
| FY2022 | Jul 25, 2020 | $33.81B | Sep 8, 2022 |
| FY2021 | Jul 27, 2019 | $33.53B | Sep 9, 2021 |
| FY2020 | Jul 28, 2018 | $31.71B | Sep 3, 2020 |
| FY2019 | Jul 29, 2017 | $29.77B | Sep 5, 2019 |
| FY2018 | Jul 30, 2016 | $26.63B | Sep 6, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $50.00M | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $1.09B | Sep 3, 2025 |
| FY2024 | Jul 29, 2023 | $1.64B | Sep 5, 2024 |
| FY2023 | Jul 30, 2022 | ($1.32B) | Sep 7, 2023 |
| FY2022 | Jul 31, 2021 | ($654.00M) | Sep 8, 2022 |
| FY2021 | Jul 25, 2020 | ($2.76B) | Sep 9, 2021 |
| FY2020 | Jul 27, 2019 | ($5.90B) | Sep 3, 2020 |
| FY2019 | Jul 29, 2018 | $5.13B | Sep 5, 2019 |
| FY2019 | Jul 28, 2018 | $1.23B | Sep 5, 2019 |
| FY2018 | Jul 29, 2017 | $20.84B | Sep 6, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $8.35B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $7.51B | Sep 3, 2025 |
| FY2024 | Jul 29, 2023 | $10.12B | Sep 5, 2024 |
| FY2023 | Jul 30, 2022 | $7.08B | Sep 7, 2023 |
| FY2022 | Jul 31, 2021 | $9.18B | Sep 8, 2022 |
| FY2021 | Jul 25, 2020 | $11.81B | Sep 9, 2021 |
| FY2020 | Jul 27, 2019 | $11.75B | Sep 3, 2020 |
| FY2019 | Jul 28, 2018 | $8.93B | Sep 5, 2019 |
| FY2018 | Jul 29, 2017 | $11.71B | Sep 6, 2018 |
| FY2018 | Jul 30, 2016 | $7.63B | Sep 6, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | $24.61B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | $20.11B | Sep 3, 2025 |
| FY2024 | Jul 29, 2023 | $8.39B | Sep 5, 2024 |
| FY2023 | Jul 30, 2022 | $8.92B | Sep 7, 2023 |
| FY2022 | Jul 31, 2021 | $11.53B | Sep 8, 2022 |
| FY2021 | Jul 25, 2020 | $14.58B | Sep 9, 2021 |
| FY2020 | Jul 27, 2019 | $20.47B | Sep 3, 2020 |
| FY2019 | Jul 28, 2018 | $25.57B | Sep 5, 2019 |
| FY2018 | Jul 29, 2017 | $30.47B | Sep 6, 2018 |
| FY2017 | Jul 30, 2016 | $28.64B | Sep 7, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | 2 | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | 2 | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | 3 | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | 2 | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | 2 | Sep 7, 2023 |
| FY2020 | Jul 25, 2020 | 0 | Sep 3, 2020 |
| FY2020 | Apr 25, 2020 | 0 | Sep 3, 2020 |
| FY2020 | Jan 25, 2020 | 0 | Sep 3, 2020 |
| FY2020 | Oct 26, 2019 | 0 | Sep 3, 2020 |
| FY2020 | Jul 27, 2019 | 0 | Sep 3, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | 2 | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | 2 | Sep 3, 2025 |
| FY2025 | Jul 29, 2023 | 3 | Sep 3, 2025 |
| FY2024 | Jul 30, 2022 | 2 | Sep 5, 2024 |
| FY2023 | Jul 31, 2021 | 2 | Sep 7, 2023 |
| FY2020 | Jul 25, 2020 | 0 | Sep 3, 2020 |
| FY2020 | Apr 25, 2020 | 0 | Sep 3, 2020 |
| FY2020 | Jan 25, 2020 | 0 | Sep 3, 2020 |
| FY2020 | Oct 26, 2019 | 0 | Sep 3, 2020 |
| FY2020 | Jul 27, 2019 | 0 | Sep 3, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 26, 2025 | 3.96B | Sep 3, 2025 |
| FY2025 | Jul 27, 2024 | 4.01B | Sep 3, 2025 |
| FY2024 | Jul 29, 2023 | 4.07B | Sep 5, 2024 |
| FY2023 | Jul 30, 2022 | 4.11B | Sep 7, 2023 |
| FY2022 | Jul 31, 2021 | 4.22B | Sep 8, 2022 |
| FY2021 | Jul 25, 2020 | 4.24B | Sep 9, 2021 |
| FY2020 | Jul 27, 2019 | 4.25B | Sep 3, 2020 |
| FY2019 | Jul 28, 2018 | 4.61B | Sep 5, 2019 |
| FY2018 | Jul 29, 2017 | 4.98B | Sep 6, 2018 |
| FY2017 | Jul 30, 2016 | 5.03B | Sep 7, 2017 |